Over-time mitral regurgitation changes following cardiac resynchronization therapy

Area of Science:

• Cardiology
• Heart Failure Research
• Medical Device Technology

Background:

• Mitral regurgitation (MR) is a significant contributor to mortality in heart failure (HF) patients.
• Cardiac resynchronization therapy (CRT) has demonstrated efficacy in improving MR in HF patients.
• The long-term maintenance of MR improvement following CRT remains an area requiring further investigation.

Purpose of the Study:

• To evaluate the pattern of MR improvement after CRT implantation.
• To assess the sustainability of MR reduction at a 6-month follow-up.
• To analyze changes in clinical and echocardiographic parameters post-CRT.

Main Methods:

• A prospective study involving 60 patients with moderate to severe HF and MR.
• Patients underwent CRT implantation and were evaluated at baseline, 3 months, and 6 months.
• Assessments included clinical status, electrocardiography, and echocardiography to measure MR, LVEF, and ventricular dimensions.

Main Results:

• Significant improvements in MR score, NYHA class, QRS duration, LVEF, and LVEDD were observed at 3 months post-CRT (p<0.001).
• These improvements were maintained or further enhanced between 3 and 6 months (p<0.0001), with the exception of the MR score showing no significant change between these time points.
• The study highlights sustained positive effects of CRT on cardiac function and MR.

Conclusions:

• Mitral regurgitation improvement following CRT implantation is sustained between 3 and 6 months.
• CRT offers a viable therapeutic option for managing MR in heart failure patients.
• The findings support the continued use of CRT for patients with heart failure and significant MR.